MXPA04005366A - Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros. - Google Patents

Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.

Info

Publication number
MXPA04005366A
MXPA04005366A MXPA04005366A MXPA04005366A MXPA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A
Authority
MX
Mexico
Prior art keywords
alpha
amino acids
chirally pure
salt
sulfonyl
Prior art date
Application number
MXPA04005366A
Other languages
English (en)
Spanish (es)
Inventor
Resnick Lynn
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46204648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04005366(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/014,304 external-priority patent/US6610734B2/en
Priority claimed from US10/166,896 external-priority patent/US6657070B2/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA04005366A publication Critical patent/MXPA04005366A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04005366A 2001-12-11 2002-11-26 Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros. MXPA04005366A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/014,304 US6610734B2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production
US10/166,896 US6657070B2 (en) 2000-12-13 2002-06-11 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
PCT/US2002/038117 WO2003050062A2 (en) 2001-12-11 2002-11-26 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS

Publications (1)

Publication Number Publication Date
MXPA04005366A true MXPA04005366A (es) 2004-09-27

Family

ID=46204648

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005366A MXPA04005366A (es) 2001-12-11 2002-11-26 Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.

Country Status (7)

Country Link
EP (1) EP1461332A4 (zh)
JP (1) JP4615861B2 (zh)
AU (2) AU2002351170B8 (zh)
CA (1) CA2470111A1 (zh)
MX (1) MXPA04005366A (zh)
TW (1) TWI260316B (zh)
WO (1) WO2003050062A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005255A (es) 2000-12-13 2004-10-14 Wyeth Corp Inhibidores de produccion de beta-amiloide de sulfonamida heterociclica.
NZ542468A (en) 2003-03-31 2009-01-31 Wyeth Corp Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
WO2005073198A1 (en) 2004-01-16 2005-08-11 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
JP2009534385A (ja) 2006-04-21 2009-09-24 ワイス キラル的に純粋なアミノアルコール中間体、それらの誘導体の製造、及びそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802981A1 (de) * 1988-02-02 1989-08-10 Basf Ag Verfahren zur reduktion reduzierbarer verbindungen
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
JP3657002B2 (ja) * 1992-08-25 2005-06-08 ジー．ディー．サール アンド カンパニー レトロウイルスプロテアーゼ阻害剤として有用なα−およびβ−アミノ酸ヒドロキシエチルアミノスルホンアミド
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine

Also Published As

Publication number Publication date
JP2005511727A (ja) 2005-04-28
AU2009251195A1 (en) 2010-01-21
WO2003050062A2 (en) 2003-06-19
CA2470111A1 (en) 2003-06-19
WO2003050062A3 (en) 2003-11-20
TWI260316B (en) 2006-08-21
AU2002351170B2 (en) 2009-09-24
AU2002351170B8 (en) 2009-10-08
EP1461332A4 (en) 2009-10-21
TW200306292A (en) 2003-11-16
AU2002351170A1 (en) 2003-06-23
EP1461332A2 (en) 2004-09-29
JP4615861B2 (ja) 2011-01-19

Similar Documents

Publication Publication Date Title
US8680329B2 (en) Process for preparation of α-ketoglutaric acid
JP2010507701A5 (zh)
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
WO2004031141A3 (en) Process for preparing fluorocarboxylic acids
CN101830818A (zh) 一种无水甜菜碱的制备方法
CN104592064A (zh) 一种2-氨基苯酚-4-磺酰胺的合成方法
MXPA04005366A (es) Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
CN104892731A (zh) 一种缩宫素多肽的合成方法
CN102531968A (zh) L-精氨酸α-酮戊二酸的制备工艺
CN102126970B (zh) 选择性沉淀分离亮氨酸、精氨酸的方法
CN106008392B (zh) 一种抗癌药物达沙替尼的中间体的制备方法
CN106905262A (zh) 一种制备高纯度4‑羟乙基哌嗪乙磺酸的方法
CN101560132B (zh) 手性氨基酸或其衍生物的消旋方法
CN104326989B (zh) 2-甲基-4-氨基-5-(氨基甲基)嘧啶的制备方法
CN113501771B (zh) 一种n-(2-氨乙基)甘氨酸衍生物的制备方法
CN109761916A (zh) 一种乳清酸的改进合成方法
CN110606811B (zh) 一种l-丝氨酸甲酯盐酸盐的合成方法
WO2019218445A1 (zh) 一种脲酶抑制剂乙酰氧肟酸的合成方法
CN103319376B (zh) 肌酸盐酸盐的制备方法
AR037776A1 (es) Produccion de alfa-aminoacidos quiralmente puros y n-sulfonil alfa-aminoacidos.
CN105506015A (zh) 一种l-天门冬氨酸的生产及母液处理回用的方法
JP2009062392A (ja) 環化法
AU2002233613A1 (en) Process and apparatus for the production of calcium bromide by liquid-liquid extraction
CN102718663A (zh) 一种5-氯-1-茚胺的合成方法

Legal Events

Date Code Title Description
FG Grant or registration